Quality assurance for the EORTC 22071–26071 study: dummy run prospective analysis

PURPOSE: The phase III 22071–26071 trial was designed to evaluate the addition of panitumumab to adjuvant chemotherapy plus intensity modulated radiotherapy (IMRT) in locally advanced resected squamous cell head and neck cancer. We report the results of the dummy run (DR) performed to detect deviati...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Radiat Oncol
Main Authors: Fairchild, Alysa, Langendijk, Johannes A, Nuyts, Sandra, Scrase, Christopher, Tomsej, Milan, Schuring, Danny, Gulyban, Akos, Ghosh, Sunita, Weber, Damien C, Budach, Wilfried
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2014
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4311463/
https://ncbi.nlm.nih.gov/pubmed/25424399
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-014-0248-9
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki